DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,418 filers reported holding DANAHER CORPORATION in Q3 2019. The put-call ratio across all filers is 0.78 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $12,470,763 | -6.8% | 49,913 | -6.9% | 0.30% | +0.7% |
Q1 2024 | $13,386,990 | +107270.8% | 53,608 | -0.5% | 0.30% | +16.6% |
Q4 2023 | $12,468 | -99.9% | 53,894 | +9.0% | 0.26% | -4.4% |
Q3 2023 | $12,271,274 | -7.0% | 49,461 | -10.1% | 0.27% | -1.5% |
Q2 2023 | $13,200,480 | -28.6% | 55,002 | -25.0% | 0.28% | -32.3% |
Q1 2023 | $18,480,580 | -9.9% | 73,324 | -5.1% | 0.41% | -14.5% |
Q4 2022 | $20,517,497 | +5.2% | 77,302 | +2.4% | 0.48% | -1.2% |
Q3 2022 | $19,498,000 | +13.1% | 75,487 | +11.0% | 0.48% | +25.6% |
Q2 2022 | $17,236,000 | -55.6% | 67,987 | -48.7% | 0.38% | -38.2% |
Q1 2022 | $38,853,000 | -10.8% | 132,456 | 0.0% | 0.62% | +10.7% |
Q4 2021 | $43,579,000 | +0.0% | 132,456 | -7.5% | 0.56% | -1.1% |
Q3 2021 | $43,572,000 | -1.9% | 143,121 | -13.5% | 0.57% | +1.8% |
Q2 2021 | $44,426,000 | +38.8% | 165,546 | +16.4% | 0.56% | +26.1% |
Q1 2021 | $32,002,000 | -3.8% | 142,179 | -5.0% | 0.44% | -8.3% |
Q4 2020 | $33,262,000 | +30.2% | 149,735 | +26.3% | 0.48% | +5.0% |
Q3 2020 | $25,538,000 | +30.1% | 118,600 | +6.8% | 0.46% | +2.0% |
Q2 2020 | $19,629,000 | +44.1% | 111,007 | +12.8% | 0.45% | -14.1% |
Q1 2020 | $13,619,000 | -46.6% | 98,399 | -40.8% | 0.52% | -9.4% |
Q4 2019 | $25,499,000 | +6.3% | 166,138 | +0.0% | 0.58% | +0.7% |
Q3 2019 | $23,985,000 | +16.4% | 166,065 | +15.2% | 0.57% | +14.6% |
Q2 2019 | $20,599,000 | +16.6% | 144,129 | +7.7% | 0.50% | +14.9% |
Q1 2019 | $17,667,000 | +31.7% | 133,823 | +2.9% | 0.44% | +18.9% |
Q4 2018 | $13,416,000 | -5.5% | 130,105 | -0.4% | 0.37% | +19.2% |
Q3 2018 | $14,200,000 | +159.7% | 130,680 | +135.8% | 0.31% | +132.6% |
Q2 2018 | $5,468,000 | -10.6% | 55,414 | -11.3% | 0.13% | +3.9% |
Q1 2018 | $6,118,000 | +5.5% | 62,483 | 0.0% | 0.13% | +12.4% |
Q4 2017 | $5,800,000 | +7.1% | 62,483 | -1.1% | 0.11% | -1.7% |
Q3 2017 | $5,418,000 | +1.6% | 63,167 | 0.0% | 0.12% | -3.4% |
Q2 2017 | $5,331,000 | +2.3% | 63,167 | +3.7% | 0.12% | -15.6% |
Q1 2017 | $5,212,000 | +8.2% | 60,941 | -1.5% | 0.14% | -1.4% |
Q4 2016 | $4,817,000 | – | 61,881 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |